ProfileGDS5822 / ILMN_2563382
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 20% 5% 3% 14% 2% 17% 9% 13% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11320
GSM1276600PDAC Late Ablation Control 29.95
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 16.23
GSM1276603PDAC Late Ablation 29.914
GSM1276604PDAC Late Ablation 33.62
GSM1303940PDAC Late Ablation_anti-CTLA4 111.817
GSM1303941PDAC Late Ablation_anti-CTLA4 26.49
GSM1303942PDAC Late Ablation_anti-CTLA4 37.813